ED ILSISTEMA NERVOSO ENTERICO? UNA GRANDE REVIEW

Disorders of the enteric nervous system — a holistic view Beate Niesler et al Abstract The enteric nervous system (ENS) is the largest division of the peripheral nervous system and closely resembles components and functions of the central nervous system. Although the central role of the ENS in congenital enteric neuropathic disorders, including Hirschsprung disease…

NEI PAZIENTI RICOVERATI CON COVID REMDESIVIR, IROSSICLOROCHINA, LOPINAVIR ED INTERFERONE BETA NON RIDUCONO LA MORTALITA’.

In inpatients with COVID-19, none of remdesivir, hydroxychloroquine, lopinavir, or interferon b -1a differed from standard care for in-hospital mortality Pan H, Peto R, et al. Question: In adults hospitalized with coronavirus disease 2019 (COVID-19), what are the effects of 4 antiviral drugs compared with local standard care without the antivirals on in-hospital mortality? Design:…

ANTIBIOTICI “DISTRUGGONO” IL MICROBIOTA INTESTINALE: UNA BUONA REVIEW

Antibiotics as Major Disruptors of Gut Microbiota Jaime Ramirez et al. Advances in culture-independent research techniques have led to an increased understanding of the gut microbiota and the role it plays in health and disease. The intestine is populated by a complex microbial community that is organized around a network of metabolic interdependencies. It is…

INTELLIGENZA ARTIFICIALE E MEDICO DI FAMIGLIA: UN GRANDE ARTICOLO DA “SALUTE INTERNAZIONALE”

Intelligenza artificiale e medicina generale Giampaolo Collecchia “… La filosofia arriva sempre troppo tardi. Come pensiero nel mondo, essa appare per la prima volta nel tempo, dopo che la realtà ha compiuto il suo processo di formazione ed è bell’e fatta… Quando la filosofia dipinge a chiaroscuro, allora un aspetto della vita è invecchiato, e,…

BARRIERA MUCOSA: IL VERO AGENTE PROVOCATORE PER LE IBD

The intestinal barrier, an arbitrator turned provocateur in IBD Mehandru S, and Colombel JF Key studies published in 2020 demonstrate that an impaired intestinal barrier precedes clinical diagnosis of inflammatory bowel disease (IBD) by years. Furthermore, studies identify novel regulators of the intestinal barrier, including intestinal macrophages and diurnal variations of diet–microbiome interactions, which could…